Many years ago now, Dr. Samuel Epstein of Chicago raised serious concerns about Tamoxifen. Perhaps more people should have been listening.
More people should be listening to the fact that annual screening mammogram promotes breast cancer. (Suggestion: Request Thermography)
Long-term use of a common breast cancer drug may hike the risk of developing a deadly second tumour, a study suggests.
Tamoxifen, given to thousands of women, prevents tumours being fuelled by the sex hormone oestrogen, and stops them returning after surgery.
But a US study links use of the drug to a four-fold raised risk of developing a more aggressive, difficult-to-treat tumour, not dependent on oestrogen.Full story